Template:Chemokine receptor modulators: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import Tags: mobile edit mobile web edit |
m 1 revision imported |
||
| (One intermediate revision by one other user not shown) | |||
| Line 91: | Line 91: | ||
| group10 = [[CCR10]] | | group10 = [[CCR10]] | ||
| list10 = | | list10 = | ||
* ''Agonists:'' [[CCL27]] | * ''Agonists:'' [[C-C motif chemokine ligand 27|CCL27]] | ||
* [[CCL28]] | * [[CCL28]] | ||
| Line 173: | Line 173: | ||
| group7 = [[ACKR3|CXCR7]] | | group7 = [[ACKR3|CXCR7]] | ||
| list7 = | | list7 = | ||
* ''Agonists:'' [[CXCL11|CXCL11 (I-TAC)]] | * ''Agonists:'' [[Conolidine]] | ||
* [[CXCL11|CXCL11 (I-TAC)]] | |||
* [[CCX771]] | |||
* [[LIH383]] | |||
* [[RTI-5152-12]] | |||
* [[Stromal cell-derived factor 1|SDF-1 (CXCL12)]] | * [[Stromal cell-derived factor 1|SDF-1 (CXCL12)]] | ||
* [[VUF15485]] | |||
* ''PAMs:'' [[Plerixafor|Plerixafor (AMD3100)]] | * ''PAMs:'' [[Plerixafor|Plerixafor (AMD3100)]] | ||
| Line 192: | Line 197: | ||
}} | }} | ||
| group4 = [[CX3C chemokine receptor|CX3C]] | | group4 = [[CX3C motif chemokine receptor 1|CX3C]] | ||
| list4 = {{Navbox|subgroup | | list4 = {{Navbox|subgroup | ||
| group1 = [[CX3CR1]] | | group1 = [[CX3C motif chemokine receptor 1|CX3CR1]] | ||
| list1 = | | list1 = | ||
* ''Agonists:'' [[Fractalkine|Fractalkine (CX3CL1)]] | * ''Agonists:'' [[Fractalkine|Fractalkine (CX3CL1)]] | ||
| Line 215: | Line 220: | ||
}} | }} | ||
}}<noinclude> | }}<noinclude> | ||
| Line 226: | Line 225: | ||
[[Category:Drug templates by receptor, channel, or pump]] | [[Category:Drug templates by receptor, channel, or pump]] | ||
</noinclude> | </noinclude> | ||
Latest revision as of 18:18, 8 March 2025
| Chemokine receptor modulators | ||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
